Greg Behar

Greg Behar is an accomplished executive currently serving as the Chief Executive Officer at Recipharm since January 2024, and as a Board Member for Bespak, NewBiologix, Sonova Group, and Amazentis. With a rich history in leadership, Greg was the President and CEO of Nestlé Health Science from July 2014 to December 2023 and contributed to various organizations as a board member, including Seres Therapeutics, Axcella, Aimmune Therapeutics, and Cerecin. Greg Behar holds an MBA from Harvard Business School and INSEAD, alongside an Engineer's Degree in Manufacturing Engineering from EPFL, and a degree from UCLA.